MacroGenics, Inc.
USD4.86
+0.05 (+1.04%)
CEO
Eric Risser
IPO Date
2013-10-10
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$4.75
Prev. Close
$4.81
Day Low
$4.70
Day High
$4.95
52W Low
$1.19
52W High
$5.08
Market Cap
$0.31B
Volume
1.35M
| -3.0 |
| 31 Dec 2023 | FY | 85.6% | -15.8% | -5.9% | -3.0% | 0.22 | 4.48 | -65.8 |
| 31 Dec 2022 | FY | 95.1% | -79.8% | -84.3% | -41.4% | 0.25 | 4.57 | -3.4 |
| 31 Dec 2021 | FY | 96.5% | -267.2% | -84.3% | -60.3% | 0.11 | 3.75 | -4.8 |
| 31 Dec 2020 | FY | 100.0% | -132.7% | -43.8% | -34.3% | 0.10 | 6.17 | -9.2 |
| 31 Dec 2019 | FY | 100.0% | -244.8% | -65.8% | -48.6% | 0.13 | 5.31 | -3.4 |
| 31 Dec 2018 | FY | 100.0% | -285.2% | -70.6% | -51.6% | 0.00 | 4.49 | -3.0 |
| 31 Dec 2017 | FY | 100.0% | -12.6% | -6.6% | -5.2% | 0.00 | 6.48 | -34.9 |
| 31 Dec 2016 | FY | 100.0% | -67.6% | -21.8% | -18.8% | 0.01 | 10.40 | -12.1 |
| -1.8 |
| 30 Sept 2025 | Q3 | 81.6% | 23.1% | 25.1% | 6.2% | 0.55 | 5.22 | 1.6 |
| 30 Jun 2025 | Q2 | 51.4% | -163.0% | -77.8% | -14.8% | 2.31 | 5.25 | -0.5 |
| 31 Mar 2025 | Q1 | 45.6% | -311.1% | -51.9% | -18.3% | 0.47 | 3.28 | -0.5 |
| 31 Dec 2024 | Q4 | 69.0% | -87.0% | -13.3% | -5.9% | 0.32 | 3.92 | -3.3 |
| 30 Sept 2024 | Q3 | 61.7% | 50.9% | 46.9% | 21.3% | 0.28 | 3.75 | 0.9 |
| 30 Jun 2024 | Q2 | 73.9% | -515.6% | -96.3% | -27.7% | 0.59 | 2.71 | -1.2 |
| 31 Mar 2024 | Q1 | 76.8% | -573.3% | -49.2% | -21.0% | 0.32 | 3.63 | -4.2 |
| 31 Dec 2023 | Q4 | -343.2% | -429.8% | -30.2% | -15.4% | 0.22 | 4.48 | -3.2 |